-
My Account
In App
My Account
BSE Live
Jan 06, 16:00Prev. Close
112.85
Open Price
112.85
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Dec 27, 11:22Prev. Close
-
Open Price
-
Bid Price (Qty.)
- (0)
Offer Price (Qty.)
- (0)
| Key Financial Ratios of Kappac Pharma (in Rs. Cr.) | Mar 16 | Mar 15 | Mar 14 | Mar 13 | Mar 12 | |
| Per Share Ratios | ||||||
| Basic EPS (Rs.) | -0.01 | -0.03 | -0.03 | -0.04 | -0.03 | |
| Diluted EPS (Rs.) | -0.01 | -0.03 | -0.03 | -0.04 | -0.03 | |
| Cash EPS (Rs.) | -0.01 | -0.02 | -0.02 | -0.02 | -0.01 | |
| Book Value [ExclRevalReserve]/Share (Rs.) | 12.56 | 12.57 | 12.59 | 10.05 | 10.09 | |
| Book Value [InclRevalReserve]/Share (Rs.) | 12.56 | 12.57 | 12.59 | 10.05 | 10.09 | |
| Dividend / Share(Rs.) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Revenue from Operations/Share (Rs.) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| PBDIT/Share (Rs.) | -0.01 | -0.02 | -0.02 | -0.02 | -0.01 | |
| PBIT/Share (Rs.) | -0.01 | -0.03 | -0.03 | -0.03 | -0.03 | |
| PBT/Share (Rs.) | -0.01 | -0.03 | -0.03 | -0.04 | -0.03 | |
| Net Profit/Share (Rs.) | -0.01 | -0.03 | -0.03 | -0.04 | -0.03 | |
| Profitability Ratios | ||||||
| PBDIT Margin (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| PBIT Margin (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| PBT Margin (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Profit Margin (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Return on Networth / Equity (%) | -0.05 | -0.20 | -0.21 | -0.34 | -0.25 | |
| Return on Capital Employed (%) | -0.05 | -0.20 | -0.21 | -0.34 | -0.25 | |
| Return on Assets (%) | -0.05 | -0.20 | -0.21 | -0.34 | -0.22 | |
| Total Debt/Equity (X) | 0.00 | 0.00 | 0.01 | 0.00 | 0.13 | |
| Asset Turnover Ratio (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Liquidity Ratios | ||||||
| Current Ratio (X) | 691.38 | 1,532.92 | 60.78 | 45.38 | 1.00 | |
| Quick Ratio (X) | 691.38 | 1,532.92 | 60.78 | 45.38 | 1.00 | |
| Inventory Turnover Ratio (X) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Dividend Payout Ratio (NP) (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Dividend Payout Ratio (CP) (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Earnings Retention Ratio (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Cash Earnings Retention Ratio (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Valuation Ratios | ||||||
| Enterprise Value (Cr.) | 341.51 | 341.51 | 2,084.81 | 134.10 | 42.59 | |
| EV/Net Operating Revenue (X) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| EV/EBITDA (X) | -15,600.94 | -7,323.60 | -42,568.83 | -2,750.97 | -1,572.73 | |
| MarketCap/Net Operating Revenue (X) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Retention Ratios (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Price/BV (X) | 8.99 | 8.98 | 54.70 | 5.61 | 1.65 | |
| Price/Net Operating Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Earnings Yield | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
